Information about the cookies used on the website
We use cookies on our website to improve the performance and content of the site. The cookies enable us to provide a more individual user experience and social media channels.

Mutual Support, Debates & Great Ideas for Improving the OH Participatory Platform

A space for dialog, co-creation, and questions 🚑 between members of our Open Heritage community.

Phase 1 of 1
Collection 15/11/2018 - ?
Process phases

Changes at "Oligonucleotide CDMO Capabilities"

Compare view mode:
HTML view mode:

Title

  • +{"en"=>"Oligonucleotide CDMO Capabilities"}
  • +{"en"=>"Oligonucleotide CDMO Capabilities"}
Deletions
Additions
  • +{"en"=>"Oligonucleotide CDMO Capabilities"}
Deletions
Additions
  • +{"en"=>"Oligonucleotide CDMO Capabilities"}

Body

  • +["

    Oligonucleotide CDMO capabilities include but are not limited to:

    \n

    DNA Oligos
    UNA and TINA oligonucleotides
    Light-activated oligonucleotides
    Chimeric oligonucleotides
    Various modified or unmodified antisense oligonucleotides
    Polypeptide-Nucleotide Conjugates
    RNA Oligos

    \n

    Chimeric oligonucleotides
    Long RNA synthesis
    CRISPR guide strand (sgRNA) synthesis
    siRNA and UsiRNA
    microRNA
    Nano self-assembled RNA drugs

    \ngid://decidim-openheritage/Decidim::Hashtag/1/_bug"]
  • +["<p><a href=\"https://cdmo.bocsci.com/manufacturing/oligonucleotide-gmp-manufacturing.html\">Oligonucleotide CDMO</a> capabilities include but are not limited to:</p>\n<p>DNA Oligos<br>UNA and TINA oligonucleotides<br>Light-activated oligonucleotides<br>Chimeric oligonucleotides<br>Various modified or unmodified antisense oligonucleotides<br>Polypeptide-Nucleotide Conjugates<br>RNA Oligos</p>\n<p>Chimeric oligonucleotides<br>Long RNA synthesis<br>CRISPR guide strand (sgRNA) synthesis<br>siRNA and UsiRNA<br>microRNA<br>Nano self-assembled RNA drugs</p>\ngid://decidim-openheritage/Decidim::Hashtag/1/_bug"]
Deletions
Additions
  • +["

    Oligonucleotide CDMO capabilities include but are not limited to:

    \n

    DNA Oligos
    UNA and TINA oligonucleotides
    Light-activated oligonucleotides
    Chimeric oligonucleotides
    Various modified or unmodified antisense oligonucleotides
    Polypeptide-Nucleotide Conjugates
    RNA Oligos

    \n

    Chimeric oligonucleotides
    Long RNA synthesis
    CRISPR guide strand (sgRNA) synthesis
    siRNA and UsiRNA
    microRNA
    Nano self-assembled RNA drugs

    \ngid://decidim-openheritage/Decidim::Hashtag/1/_bug"]
Deletions
Additions
  • +["<p><a href=\"https://cdmo.bocsci.com/manufacturing/oligonucleotide-gmp-manufacturing.html\">Oligonucleotide CDMO</a> capabilities include but are not limited to:</p>\n<p>DNA Oligos<br>UNA and TINA oligonucleotides<br>Light-activated oligonucleotides<br>Chimeric oligonucleotides<br>Various modified or unmodified antisense oligonucleotides<br>Polypeptide-Nucleotide Conjugates<br>RNA Oligos</p>\n<p>Chimeric oligonucleotides<br>Long RNA synthesis<br>CRISPR guide strand (sgRNA) synthesis<br>siRNA and UsiRNA<br>microRNA<br>Nano self-assembled RNA drugs</p>\ngid://decidim-openheritage/Decidim::Hashtag/1/_bug"]
Version number 1 out of 2 Show all versions Go back to proposal
Version author
Avatar: Krystal Beily Krystal Beily
Version created at 30/05/2023 07:35

You need to enable all cookies in order to see this content.

Change cookie settings